To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
DMCPA
DMCPA, or 4-methyl-2,5-methoxycyclopropylamine, is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved), the dosage range is listed as 15-20mg, and the duration is listed as 4-8 hours. DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. Shulgin gives it a +++ on the Shulgin Rating Scale. Additional recommended knowledgePharmacologyVery little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA. See alsoCategorization
|
||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "DMCPA". A list of authors is available in Wikipedia. |